Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0000899243-17-003500

Options or other derivatives

  • Chief Medical Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Talamo Jonathan H. · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-01-31 Grant or award : show line 1 in the form Stock Option (Right to Buy) +60,000 $6.56 2027-01-30 60,000 60,000 D
Loading xslF345X03/doc4.xml…